Literature DB >> 21523453

[Therapeutic strategies in erosive digital polyarthrosis].

E Sahinbegovic1, G Schett.   

Abstract

One of the most common forms of osteoarthritis is hand osteoarthritis. A subgroup, termed erosive hand osteoarthritis (EHOA), shows a highly destructive disease course with involvement of multiple joints, swelling as well as cartilage and bone destruction leading to progressive loss of hand function. EHOA is characterized by subchondral erosions of the finger joints as well as ankylosis. No disease modifying therapy is currently available for the treatment of EHOA and treatment options are confined to the control of symptoms. Acetaminophen and non-steroidal anti-inflammatory drugs are used to treat the signs and symptoms. So far cytokine blocking agents have not shown a convincing therapeutic effect and the effect size of chondroitin sulfate and bisphosphonates in EOHA is small.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21523453     DOI: 10.1007/s00108-010-2768-1

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  37 in total

Review 1.  New guidelines for topical NSAIDs in the osteoarthritis treatment paradigm.

Authors:  Roy D Altman
Journal:  Curr Med Res Opin       Date:  2010-11-11       Impact factor: 2.580

2.  Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.

Authors:  Jia Qing Huang; Subbaramiah Sridhar; Richard H Hunt
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

3.  Soluble interleukin 2 receptors and treatment with hydroxychloroquine in erosive osteoarthritis.

Authors:  L Punzi; N Bertazzolo; M Pianon; M Michelotto; S Todesco
Journal:  J Rheumatol       Date:  1996-08       Impact factor: 4.666

Review 4.  Osteoarthritis of the peripheral joints.

Authors:  Ingemar F Petersson; Lennart T H Jacobsson
Journal:  Best Pract Res Clin Rheumatol       Date:  2002-12       Impact factor: 4.098

5.  Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.

Authors:  Masahiko Kobayashi; Ginette R Squires; Aisha Mousa; Michael Tanzer; David J Zukor; John Antoniou; Ulrich Feige; A Robin Poole
Journal:  Arthritis Rheum       Date:  2005-01

6.  Sex differences in osteoarthritis of the hip and knee.

Authors:  Mary I O'Connor
Journal:  J Am Acad Orthop Surg       Date:  2007       Impact factor: 3.020

7.  Numerical scoring systems for the anatomic evolution of osteoarthritis of the finger joints.

Authors:  G Verbruggen; E M Veys
Journal:  Arthritis Rheum       Date:  1996-02

8.  Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study.

Authors:  X Chevalier; P Goupille; A D Beaulieu; F X Burch; W G Bensen; T Conrozier; D Loeuille; A J Kivitz; D Silver; B E Appleton
Journal:  Arthritis Rheum       Date:  2009-03-15

9.  Association of erosive hand osteoarthritis with a single nucleotide polymorphism on the gene encoding interleukin-1 beta.

Authors:  A G Stern; M R C de Carvalho; G A Buck; R A Adler; T P S Rao; D Disler; G Moxley
Journal:  Osteoarthritis Cartilage       Date:  2003-06       Impact factor: 6.576

10.  EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; B F Leeb; L Alekseeva; N K Arden; J W Bijlsma; F Dinçer; K Dziedzic; H J Häuselmann; G Herrero-Beaumont; P Kaklamanis; S Lohmander; E Maheu; E Martín-Mola; K Pavelka; L Punzi; S Reiter; J Sautner; J Smolen; G Verbruggen; I Zimmermann-Górska
Journal:  Ann Rheum Dis       Date:  2006-10-17       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.